Can Blastocyst Morphometrics Be a Non-invasive Predictive Marker for Clinical Pregnancy in In vitro Fertilisation Cycles? A Prospective Cohort Study
Neeta Singh, Supriya Kumari, Monika Saini, Maroof Ahmad Khan
A
BSTRACT
Background:
Blastocyst diameter is a key morphometric indicator used to predict implantation. Some studies suggest, well-expanded blastocysts generally demonstrate significantly higher clinical pregnancy and live birth rates compared to smaller embryos.
Aim:
The aim of this study was to investigate the predictive efficacy of morphometric parameters of a blastocyst on clinical pregnancy in
Settings and Design:
This was a prospective cohort study conducted at a tertiary care academic institution, involving 84 IVF/intracytoplasmic sperm injection cycles with a single blastocyst transfer in the fresh IVF cycle.
Materials and Methods:
All the blastocysts were assessed using a calibrated annotation tool in Embryo viewer (EmbryoScope, Vitrolife, Sweden) to measure specific variables, such as maximum blastocyst width and area of each blastocyst at 118–120 h post-insemination, just before embryo transfer.
Statistical Analysis Used:
Continuous variables were compared using independent t-test or Mann Whitney U-test. For three -group comparisons, analysis of variance or the Kruskal-Wallis test was applied.
Results:
Among the women who had a clinical pregnancy, the mean width of the transferred blastocyst was significantly (
Conclusion:
Objective morphometric evaluation of blastocyst width and area provides a simple, non-invasive and reliable predictor of clinical pregnancy in IVF cycles.